CDMO News
Kincell Bio Acquires Imugene’s cGMP Facility in Landmark Deal
Imugene, Ltd. and Kincell Bio have announced a strategic manufacturing and process development partnership. The partnership includes the sale of Imugene’s North Carolina cGMP manufacturing facility and the transfer of process and analytical development activities to Kincell. Under the agreement, Kincell
17 April 2024
Stay ahead of trends and best practices
